NLRP3 and Cognitive impairment: In summary, several studies have evaluated the analgesic actions of MCC950 in different animal pain models [30,31,32], but the effect of this NLRP3 inflammasome inhibitor on the affective and cognitive disorders accompanying PTX-provoked neuropathic pain and its main mechanisms of action have not been investigated.